🌐 EnglishEN

AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

← Trials
🧪

Observational Study on Endometrial Stromal Tumors

Recruitingn/aAges 18 Years - 80 YearsFemaleItalian Sarcoma Group
NCT02829437 on ClinicalTrials.gov ↗
💬

In plain words

What the trial is, and whether it could suit you

Observational, retrospective and prospective study on Endometrial Stromal Tumor (EST)

Sign in to get the eligibility rules as simple questions to take to your doctor.

Sign in
📋 Eligibility rules (as published)
Inclusion Criteria: * patients with a diagnosis of Endometrial Stromal Tumor (EST) according to the World Health Organization (WHO) classification 2003 or 2014 * Informed consent signature Exclusion Criteria: * patients with different diagnosis from EST
💊

What it tests

  • Treatment for EST
📍

Where

13 sites
Istituto Scientifico Romagnolo per lo Studio e la Cura dei Tumori - IRST
Meldola, Italy
Fondazione IRCCS Istituto Nazionale dei Tumori
Milan, Italy
Istituto Europeo di Oncologia
Milan, Italy
Azienda Ospedaliera Universitaria Paolo Giaccone
Palermo, Italy
Centro di Riferimento Oncologico di Aviano
Aviano, Italy
Istituto Oncologico Veneto
Padova, Italy
Fondazione del Piemonte per l'Oncologia IRCC Candiolo
Candiolo, Italy
Policlinico S.Orsola Malpighi - Unit of Medical Oncology
Bologna, Italy

…and 5 more on ClinicalTrials.gov.

🤝 Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible — always decide together with your own doctor.
🛡️

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it — not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use · Privacy